Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
6.97%
↑ 103% vs avg
Percentile
P100
Near historical high
Streak
4 yr
Consecutive growthExpanding
Average
-272.43%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | 6.97% | +135.3% |
| 2024 | -19.78% | +84.2% |
| 2023 | -124.87% | +84.7% |
| 2022 | -818.58% | +25.5% |
| 2021 | -1098.61% | -781.9% |
| 2020 | -124.57% | - |
| 2019 | 0.00% | - |
| 2018 | 0.00% | - |